age ~80
from Westlake, LA
Technical director
Formula One person
T cell antigen receptor, CD28 co-stimulation, CTLA-4 as an inhibitory molecule, development of anti-CTLA-4 as antibody to treat cancer, with FDA-approval of ipilimumab (BMS)
President
University of Texas at Austin
Area of science:Immunology
Specialty:Director • Immunologist • Leader
Academic degree:Professor
He has received numerous awards, including the Centeon Award for Innovative Breakthroughs in Immunology, the William B....
Author
James E. Allison
ISBN #
0764116339